At AbbVie, we are passionate about developing advanced therapies to help address the world’s greatest health challenges. We also are committed to providing access to therapies that are not yet approved for use to people who are suffering from a serious or life-threatening illness or condition and might potentially benefit from these medicines.
To do that, AbbVie has developed a Pre-Approval Access to Investigational Drugs Policy. It outlines important considerations we take into account when evaluating a doctor’s request to use investigational drugs in a patient with a serious or life-threatening illness or condition.